Fundamental Analysis
78 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +2371.3% | +831.6% | 3 / 3 | -5.6% | +15.92 pp | +13.36 pp | +3.3% | 0.00 | 18.67 | 19,4 | −5,6% | 2,5 | +2.371,3% | 18.67 | 37.92 | −50,8% |
| Pts | 12 | 12 | 12 | 0 | 12 | 12 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 7.200 (close price on 2026-10-16)EPS (TTM): 385,7
Financial charts
1.Revenue & growth
VND bn19,4Q2/26
1.Revenue & growth
VND bn19,4Q2/26
2.Profit & growth
VND bn2,49Q2/26
3.Profit mix (Penman)
VND bn7,14Q2/26
4.Margins & cost structure
%16.6%Q2/26
5.Returns & cash cycle
% · days3.2%Q2/26
6.Earnings quality & cash
VND bn15,1Q2/26
7.Asset structure
VND bn382Q2/26
8.Funding & debt health
VND bn · times382Q2/26
9.Revenue backlog
VND bn183Q2/26
10.Valuation
times · %18,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %187Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
61.8%
averaged over 2 quarter(s)
Quarters at 25%+ growth
3/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26